KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49
Check against the official notice below — it lists the full affected range.
Hospira Inc. is recalling Ketorolac Tromethamine Injectable, USP 60 mg (30 mg/mL) in 2 mL single-dose vials for intravenous or intramuscular use due to crystallization in the product. The recall affects approximately 4,339,500 vials distributed under the Hospira label and 341,100 vials under the NOVAPLUS label. The affected product was distributed nationwide in the United States as well as internationally to Guam and Singapore.
The recall involves multiple lot numbers with expiration dates ranging from February 2015 through October 2016, identified by lot numbers such as 26-098-DK, 29-239-DK, 29-240-DK, and others through lot 46-306-DK. The source document does not specify what actions affected consumers should take in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
Crystallization
Reason for recall: Crystallization Distribution: U.S. Nationwide and International: Guam and Singapore. Quantity: HOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vials Lot/code info: NDC 0409-3796-01, Lot number: 26-098-DK, Exp. Date:1FEB2015; Lot number: 29-239-DK, 29-240-DK, Exp. Date:1MAY2015; Lot number: 34-540-DK, Exp. Date:1OCT2015; Lot number: 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, Exp. Date:1JAN2016; Lot number: 41-282-DK, 41-284-DK, Exp. Date:1MAY2016; Lot number: 44-076-DK, Exp. Date:1AUG2016; Lot number: 45-240-DK, Exp. Date:1SEP2016 and Lot number: 46-306-DK, Exp. Date:1OCT2016 AND NOVAPLUS label NDC 0409-3796-49, Lot number: 26-097-DK, Exp. Date:1FEB2015.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.